Picard Medical, Inc.
Here’s whether Picard Medical, Inc. (PMI) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-21.22% over 10 days); RSI 17 — oversold; 3-month momentum negative (-86.8%); rising volume on a downtrend (distribution, 2.53x avg). Currently 98.9% off its 52-week high. Score: -4/7.
PMI is trading below its 200-day MA (—) — a key warning sign the longer-term trend is under pressure. An RSI of 17.1 has dropped into oversold territory, which has historically preceded short-term bounces. With ~9 months of trading history, the return since first available bar is -96.7%. The current 98.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.